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Background: Gilles de la Tourette syndrome (TS) is a complex neuropsychiatric disorder
defined by the presence of motor and phonic tics, but often associated with psychiatric
comorbidities. The main objective of this study was to explore the clinical presentation
and comorbidities of TS.
Method: We analyzed clinical data obtained from a large sample (n = 1032; 529
children and 503 adults) of patients with tic disorders from one single German TS center
assessed by one investigator. Data was collected with the help of an expert-reviewed
semi-structured interview, designed to assess tic severity and certain comorbidities.
Group comparisons were carried out via independent sample t-tests and chi-square
tests.
Results: The main findings of the study are: (1) tic severity is associated with
the presence of premonitory urges (PU), copro-, echo-, and paliphenomena and
the number of comorbidities, but not age at tic onset; it is higher in patients with
comorbid obsessive-compulsive disorder (OCD) than in patients with comorbid attention
deficit/hyperactivity disorder (ADHD). (2) PU were found to be highly associated with “not
just right experiences” and to emerge much earlier than previously thought alongside
with the ability to suppress tics (PU in >60% and suppressibility in >75% at age 8–10
years). (3) Self-injurious behavior (SIB) is highly associated with complex motor tics
and coprophenomena, but not with OCD/obsessive-compulsive behavior (OCB). While
comorbid ADHD is associated with a lower ability to suppress tics, comorbid depression
is associated with sleeping problems.
Discussion: Our results demonstrate that tic severity is not influenced by age at
onset. From our data, it is suggested that PU represent a specific type of “not just
right experience” that is not a prerequisite for tic suppression. Comorbid ADHD reduces
patients’ ability of successful tic suppression. Our data suggest that SIB belongs to the
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coprophenomena spectrum and hence should be conceptualized as a complex tic rather
than a compulsion. Finally, this study strongly supports the hypothesis that TS+OCD is a
more severe form of TS and that comorbid OCD/OCB, depression, and anxiety belong to
the TS spectrum, while ADHD should be better conceptualized as a separate problem.
Keywords: Tourette syndrome, tics, comorbidities, ADHD, OCD, premonitory urges, self-injurious behavior,
depression
INTRODUCTION
A part of the broad spectrum of tic disorders—including
provisional tic disorder and persistent (chronic) tic disorder—
Gilles de la Tourette syndrome (TS) is a neuropsychiatric
disorder with an onset in childhood. This developmental disorder
is characterized by the presence of multiple motor tics and at least
one phonic tic for a minimum period of 1 year, beginning before
18 years of age and occurring in bouts (American Psychiatric
Association, 2013). Typically, tics begin to appear between 5–7
years of age, follow a waxing and waning course, reach their peak
severity between 10 and 12 years of age, and decline drastically
or even vanish completely by the end of adolescence (Leckman
et al., 1998). Not only is TS found among people in all countries,
cultures, and ethnic groups, but its main characteristics are also
mostly similar across such different populations (Tanner and
Goldman, 1997), with the estimated prevalence ranging between
1% (Robertson et al., 2009) and 5.26% (Cubo et al., 2011), the
latter relatively high percentage conveying that TS in the general
community is milder and more ubiquitous than its prevalence
estimates based on its occurrence in clinical settings (Robertson,
2000). Relevant literature also points toward a clear sex difference
in prevalence of TS, with it being approximately four times more
common in males than in females (Robertson, 1994; Tanner and
Goldman, 1997; Freeman et al., 2000).
The vast majority of individuals with TS report a certain
discomfort or feeling of pressure before a tic occurs—either
focal and specific to a particular anatomical location or
more generalized—called “premonitory urge” (PU), that tends
to intensify before the tic occurs and is usually mitigated
temporarily once the individual performs the tic (Leckman et al.,
1993).
Particularly in more severely affected patients, simple
motor and phonic tics are often accompanied by different
forms of complex tics including coprophenomena—such as
making socially inappropriate gestures (copropraxia) or verbal
expressions (coprolalia)—in which symptoms tend to manifest
during the preadolescent period when tics are at their most
severe (Freeman et al., 2009), echophenomena such as imitating
gestures (echopraxia) and words or phrases (echolalia), and
paliphenomena such as phonic blocking and repetition (palilalia).
Additionally, TS is considerably comorbid with attention
deficit/hyperactivity disorder (ADHD), obsessive-compulsive
disorder (OCD) or (subclinical) obsessive-compulsive behavior
(OCB), anxiety disorders, depression, self-injurious behavior
(SIB), rage attacks, and to a lesser extent with learning disorders,
personality disorders, and other behavioral disorders (Robertson,
2000). Freeman et al. (2000) found that at all ages, a mere
12% of the clinical population with TS have no reported
comorbidity.
Robertson and Baron-Cohen (1998) have provided a relatively
clear clinical division of TS: (i) “pure TS,” including almost only
motor and phonic tics; (ii) “full blown TS,” consisting of related
echo-, copro-, and paliphenomena; and (iii) “TS plus” (first
coined by Packer, 1997), which includes cases of those who also
have SIB, ADHD, severe OCB, or OCD, as well as other severe
psychopathologies such as depression, anxiety, and antisocial
behaviors. Another classification was proposed by Robertson
and Cavanna (2007), in which “cluster 1” consisted of only
simple tics, “cluster 2” involved tics, ADHD, and aggression,
whilst “cluster 3” included tics, and affective disorders such as
OCD/OCB, depression, and anxiety. The second classification is
in line with research indicating that depression, anxiety, OCD,
and OCB are all a part of the TS spectrum, whereas ADHD is
somewhat separate (Lebowitz et al., 2012; Hirschtritt et al., 2015;
Trillini and Müller-Vahl, 2015).
In their multisite study, Freeman et al. (2000) analyzed data
obtained from 3500 individuals diagnosed with TS obtained
from 64 different centers across 22 countries, and established
several findings. They reported that the mean age at onset of
tics was 6.4 years. The most common reported comorbidity
was ADHD at 60% followed by history of sleeping problems
(37%) and OCB (32%). In terms of gender differences, they
confirmed not only the well-known male:female ratio (4.3:1),
but also found that males are more likely to have comorbid
disorders such as conduct disorder (CD)/oppositional defiant
disorder (ODD), ADHD, pervasive developmental disorders,
anger control problems, specific learning disability, stuttering,
social skills problems, and pre-/perinatal-problems than females,
whereas females showed significantly higher rates for SIB and
trichotillomania. Males were also found to have a significantly
higher comorbidity score (2.06) than females (1.83). Symptoms
such as sleeping problems, coprolalia, SIB, and anger control
problems were found to be positively associated with the
comorbidity score. With respect to associated psychopathology,
their results also showed that sleeping problems were twice as
likely to occur in the comorbid group as opposed to the “TS only”
group (without comorbidities).
Through this study, we aim to extend our knowledge of
possible differences in the clinical presentation and nature of
TS-related phenomena/various tic symptoms based on gender,
age groups, and single comorbidity subgroups of TS, and
thereby achieve a better understanding of the factors producing
variations in order to engage in better subtyping of TS. Therefore,
we used a large database—consisting purely of data gathered
during the first evaluation of every patient at the TS center—as
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a suitable starting point for studying a large sample (n = 1032)
from a single research site, thereby controlling for inter-site
variance. We also posit a more specific hypothesis that whilst
comorbidities such as OCD, anxiety, depression, and SIB are
more related to the TS spectrum, comorbidities like ADHD and
rage attacks tend to be slightly independent of it, as has been
suggested earlier (Lebowitz et al., 2012; Hirschtritt et al., 2015;
Trillini and Müller-Vahl, 2015).
METHODS
This study bases on a large data set obtained from only one
single large German TS center at the Clinic of Psychiatry,
Socialpsychiatry, and Psychotherapy at the Hannover Medical
School (MHH). It is the largest TS center in all of Germany
with an outpatient clinic which treats both adults and children.
The waiting time for an appointment ranges between 2 and 3
months. The administration of this institution allows patients
to visit the outpatient clinic without the need for a referral by
another medical professional. The medical costs incurred by the
patients’ families are covered by health insurance. Thus, patients
from all over Germany—and in some cases even from abroad—
present at this TS center. All patients included in this study had
not only been personally seen by one of the authors (KMV), but
their medical history was also personally looked into by her in
each case. KMV is both a neurologist and an adult psychiatrist
and a well-experienced specialist for tic disorders.
Clinical data was elicited over a period of nearly 20 years
(1995–2013) from 1032 patients consisting of 529 children and
503 adults (median age = 17; SD = 12.91) with various tic
disorders. The diagnoses of different form of tic disorders were
made according to DSM criteria valid at that time (DSM-III-R–
DSM-IV-TR). All subjects were prospectively interviewed using
a clinician-reviewed semi-structured interview assessing several
different aspects including tics and comorbidities. This schedule
closely resembles the National Hospital Interview Schedule,
developed by Robertson and Eapen (1996), and its credibility
was established based on the expertise of one of the authors
(KMV). Lifetime data for 9 motor and phonic tic symptoms
were obtained: simple motor (MT) and phonic tics (PT), complex
MT and PT (including all different forms of complex tics), and
specifically coprolalia, copropraxia, echolalia, echopraxia, and
palilalia (each symptom was scored as either present or absent).
In addition, we asked for age at tic onset (separately for MT and
PT), suppressibility of tics (yes/no), and presence of PU (yes/no),
including the nature/localization of the PU (local, diffused, or
uncertain).
Current tic severity was assessed on the day of diagnosis
at MHH using the Shapiro Tourette-Syndrome Severity Scale
(STSS), which contains five variables with matching rating
scales as follows: (1) tics noticeable to others (0–3), (2) tics
elicit comments or curiosity (0–1), (3) patient considered odd
or bizarre (0–2), (4) tics interfere with functioning (0–2), (5)
incapacitated, homebound or hospitalized (0–1). The total score
ranges from 0 to 9 with the following interpretation: 0 = none,
0−<1 = very mild, 1 − <2 = mild, 2 − <4 = moderate, 4 −
<6=marked, 6− 8= severe, and>8 – 9= very severe (Shapiro
et al., 1988). The corresponding Global Severity Ratings (GSR)
range from 0 (indicating “none”) to 6 (indicating “very severe”).
Lifetime prevalence for the following comorbidities was
evaluated based on the semi-structured clinical interview:
hyperactivity, inattention, rage attacks, anxiety (including
different forms of anxiety disorders including phobias, panic
disorders, and general anxiety disorder), depression, OCD,
SIB, and sleeping problems. ADHD was diagnosed for each
participant based on the presence of either hyperactivity or
inattention, and hence these two are considered one comorbidity.
OCB, being a mild form of OCD, was assessed, but not
considered as a comorbidity. Specific obsessive-compulsive (OC)
symptoms such as obsessions and compulsions—particularly
those of counting, checking, ordering, washing, and “not just
right experiences”—were also assessed. For the assessment of
comorbidities, no validated rating scales were used. Diagnoses of
psychiatric comorbidities were based either on patients’ history
or—in case of current symptomatology—on DSM criteria. A
comorbidity score was calculated by adding up the total number
of comorbidities for each patient as suggested earlier (Freeman
et al., 2000), ranging from 0 to 6 (including OCD, ADHD, rage
attacks, anxiety, depression, and SIB).
Several group comparisons were undertaken. Patients
diagnosed with TS according to DSM (“TS group”) were
categorized as “TS only”—consisting of those individuals with
no comorbidities (as defined above)—and “TS + comorbidities”
(equivalent of the “TS plus” sub-group coined by Packer, 1997)—
comprised those TS patients with ≥1 comorbidity (including
OCD, ADHD, rage attacks, anxiety, depression, and SIB). In
addition, we conducted two further subgroup comparisons: (i)
TS+OCD (excluding ADHD but including other comorbidities)
vs. TS+ADHD (excluding OCD/OCB but including other
comorbidities) in order to further investigate the hypothesis
that OCD, but not ADHD, is part of the TS spectrum; and (ii)
TS+OCD/OCB/anxiety/depression/SIB vs. TS+ADHD+rage
attacks in order to verify the validity of the classification of TS
suggested by Robertson and Cavanna (2007).
All data analyses were carried out using the Statistical Package
for Social Sciences (V.21.0 for Mac, SPSS Inc.) and Microsoft
Excel Mac 2011. Z-score tests of proportion were carried out to
measure gender differences for various clinical features of TS and
associated disorders. Pearson’s Chi-square tests were conducted
to test for associations between categorical variables measuring
the presence of several comorbidities. ANOVA and t-tests were
conducted to test for gender differences and differences in tic
severity in continuous variables. Alpha value was set at 0.05 (two-
tailed). Due to a few issues related to data collection, some of
the fields in the database were left blank, thereby resulting in an
incomplete database and consequently certainmissing values, the
absolute numbers and percentages of which have beenmentioned
at the appropriate parts of the results section.
RESULTS
Of the entire sample of 1032 patients, 529 (51.3%) were
children (<18 years of age) whilst 503 (48.7%) were adults
(≥18 years of age). Nine hundred and seventy-eight patients
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had TS, 40 patients were diagnosed with chronic motor tics
(CMT), and the remaining 14 had other tic disorders, such as
transient (provisional) or chronic (persistent) vocal or other
tic disorders. Unless otherwise specified, all the results pertain
to the entire sample. Further, details for the CMT group will
be provided elsewhere (Müller-Vahl et al., in preparation).
Depending on the presence of comorbidities we found: “TS
only” (n = 75; 7.2%), “TS + comorbidities” (n = 898; 87.0%),
TS+OCD (n = 45; 4.4%), TS+ADHD (n = 102; 9.9%),
TS+OCD/OCB/anxiety/depression/SIB (n = 209; 20.3%), and
TS+ADHD+rage attacks (n= 56; 5.4%).
Tics: Age at Onset and Tic Severity
The mean age at time of assessment was 20.9 years (range 4–72;
SD: 12.91). The mean age at onset of tics was 6.97 years (range,
0–21; SD: 3.17). Only one of the 978 participants claimed that his
tics started at the age of 21 years, although all other respective
DSM criteria were met. The mean age at onset for MT was
7.51 years (range, 0–53; SD: 3.95) whereas that for PT was 9.76
years (range, 0–48; SD: 5.58). The mean age at diagnosis was
18.9 years (range, 4–72; SD: 12.72). Mean tic severity ratings
(GSR) according to STSS were 2.79 when considering the entire
sample (range, 1–6; SD: 1.17) and 2.83 within the TS group
(range, 1–6; SD: 1.17). Table 1 shows tic severity across the
entire sample demonstrating that even in a tertiary referral
center like ours, tic severity is very mild to moderate in almost
three-quarter of patients. No significant relationship was found
between age at onset of tics and tic severity as measured by the
STSS [F(5) = 0.817; n.s.]. Table 2 shows percentages of the total
sample developing tics at various age ranges.
TABLE 1 | Tic severity according to STSS-GSR (range, 1–6) across the
sample (n = 1032).
STSS-GSR Number (%)
1 = very mild 120 (12.0)
2 = mild 343 (34.3)
3 = medium 265 (26.5)
4 = marked 176 (17.6)
5 = severe 90 (9.0)
6 = very severe 5 (0.5)
STSS-GSR, Global Severity Rating of the Shapiro Tourette-Syndrome Severity Scale.
TABLE 2 | Age range at tic onset.
Age range [years] Tic onset
N (%)
<6 352 (34.1)
6–10 543 (52.6)
11–15 119 (11.6)
16–18 17 (1.6)
>18 1 (0.1)
N = number of cases.
Considering the three age groups (based on current age of the
patient) according to age dependency of tic severity provided by
Bloch et al. (2006), we found a significant positive association
between mean tic severity and age groups [F(2) = 31.658;
p < 0.001]: age <10 years (n = 184): mean STSS-GSR = 2.33,
age 10–12 years (n = 198): mean STSS-GSR = 2.52, and age
>12 years (n = 650): mean STSS-GSR = 3.00. For the purpose
of finding the age group where tics reach their worst severity,
in addition, for the following age groups mean STSS-GSR
were calculated and again demonstrated a significant positive
relationship between STSS-GTS and age groups [F(5) = 12.688;
p < 0.001]: <6 years (n = 13): mean STSS-GSR = 2.31, 6–10
years (n = 251): mean STSS-GSR = 2.38, 11–15 years (n = 205):
mean STSS-GSR= 2.66, 16–20 years (n= 141): mean STSS-GSR
= 2.99, 21–25 years (n= 100): mean STSS-GSR= 3.02,>25 years
(n= 322): mean STSS-GSR= 3.06.
In addition, mean tic severity (STSS-GSR) was found to be
highly associated with the comorbidity score [F(6) = 19.945;
p < 0.001; Table 3]. Mean STSS-GTS was significantly lower in
the “TS only” group (2.20) compared to the “TS + comorbidity”
group [2.88, [t(945) = −4.937; p < 0.001]]. Further, details
regarding tic severity depending on the presence of one or more
comorbidities are given in Table 4.
Coprophenomena, Echophenomena,
Palilalia
With regards to specific complex tics (“full blown TS”), 290
patients (28.1%) reported coprophenomena, of which 247 (24%)
reported coprolalia and 160 (15.5%) copropraxia, 290 patients
(28.1%) claimed to have echolalia and 238 (23.1%) echopraxia,
and 339 patients (33%) reported palilalia. Results showing
associations between presence of various complex tics and tic
severity are shown in Table 5.
In addition, we found a significant association between
coprophenomena and comorbidity score (X2 = 126.823;
TABLE 3 | Association between number of comorbidities (=comorbidity
score) and mean tic severity*.
Number of
comorbidities
N Mean tic
severity
SD Std.
Error
95% Confidence
Interval for Mean
Lower
bound
Upper
bound
0 82 2.11 0.817 0.09 1.93 2.29
1 179 2.38 1.006 0.075 2.23 2.53
2 206 2.71 1.083 0.075 2.56 2.86
3 217 2.82 1.147 0.078 2.67 2.97
4 170 3.02 1.186 0.091 2.84 3.20
5 107 3.38 1.264 0.122 3.14 3.63
6 36 3.69 1.091 0.182 3.33 4.06
*comorbidity score including OCD, anxiety, depression, SIB, rage attacks, and ADHD,
mean tic severity (according to SPSS-GSR; missing data: n = 35).
OCD, obsessive-compulsive disorder; OCB, obsessive-compulsive behavior; ADHD,
attention-deficit hyperactivity disorder; SIB, self-injurious behavior; STSS-GSR, Global
Severity Rating of the Shapiro Tourette-Syndrome Severity Scale; N, number of cases;
SD, standard deviation; Std., Standard.
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TABLE 4 | Tic severity depending on the presence (±) of different comorbidities*.
Comorbidity N Mean tic severity SD Std. Error Mean t-value Significance
OCD† + 97 3.15 1.143 0.038 3.266 p < 0.001
− 901 2.74 1.307 0.133
Anxiety + 314 3.05 1.106 0.042 4.88 p < 0.001
− 684 2.67 1.250 0.071
Depression + 228 3.15 1.130 0.041 5.453 p < 0.001
− 771 2.68 1.218 0.081
SIB + 392 3.19 1.039 0.042 9.201 p < 0.001
− 604 2.52 1.235 0.062
Rage attacks + 577 2.96 1.081 0.053 5.642 p < 0.001
− 420 2.54 1.198 0.050
ADHD† + 449 2.92 1.174 0.050 3.256 p < 0.001
− 550 2.68 1.146 0.054
TS only 75 2.20 0.870 0.100 −4.937 p < 0.001
TS + comorbidities 872 2.88 1.172 0.04
TS+OCD 45 3.07 1.388 0.209 2.434 p < 0.05
TS+ADHD 102 2.57 0.956 0.099
TS+OCD/OCB/Anxiety/Depression/SIB 205 2.66 0.908 0.125 1.424 n.s.
TS+ADHD+rage attacks 53 2.42 1.155 0.081
*comorbidities including OCD, anxiety, depression, SIB, rage attacks, and ADHD, mean tic severity according to SPSS-GSR (missing data: n = 35).
†
groups include patients having other miscellaneous comorbidities and are therefore larger in number than the “TS+OCD” and “TS+ADHD” groups, which indicate a purer form of the
stated comobidity.
OCD, obsessive-compulsive disorder; OCB, obsessive-compulsive behavior; ADHD, attention-deficit hyperactivity disorder; SIB, self-injurious behavior; STSS-GSR, Global Severity
Rating of the Shapiro Tourette-Syndrome Severity Scale; N, number of cases; SD, standard deviation; Std., Standard.
TABLE 5 | Tic severity* depending on presence (±) of certain complex tics.
Complex tic N Mean
STSS-
GSR
SD Std.
error
t-value Significance
Coprophenomena + 278 3.36 1.255 0.075 −10.093 p < 0.001
− 721 2.57 1.052 0.039
Coprolalia + 239 3.46 1.262 0.082 −10.742 p < 0.001
− 757 2.58 1.050 0.038
Copropraxia + 154 3.49 1.280 0.103 −8.473 p < 0.001
− 843 2.66 1.096 0.038
Echolalia + 280 3.21 1.220 0.073 −7.438 p < 0.001
− 717 2.62 1.100 0.041
Echopraxia + 227 3.19 1.292 0.086 −6.101 p < 0.001
− 770 2.67 1.098 0.040
Palilalia + 325 3.22 1.175 0.065 −8.406 p < 0.001
− 670 2.58 1.104 0.043
*according to STSS-GSR.
STSS-GSR, Global Severity Rating of the Shapiro Tourette-Syndrome Severity Scale; N,
number of cases; SD, standard deviation; Std., Standard.
p < 0.001), echophenomena and comorbidity score (X2 =
76.14; p < 0.001), and paliphenomena and comorbidity score
(X2 = 87.38; p < 0.001). Prevalence rates of coprophenomena
demonstrated a significant association with age (X2 = 23.227;
p < 0.001): <10 years = 36 (19.6%), 10–12 years = 46
(23.2%), and >12 years = 208 (32%). There were also significant
associations between age group and other complex tics such
as echolalia (X2 = 7.736; p < 0.05), echopraxia (X2 =
24.737; p < 0.001), and palilalia (X2 = 7.111; p < 0.05).
In terms of individual comorbidities, coprophenomena were
most highly associated with SIB (X2 = 60.302; p < 0.001;
with both coprolalia and copropraxia having similarly significant
associations), followed by depression (X2 = 34.484; p <
0.001), rage attacks (X2 = 33.800; p < 0.001); ADHD (X2 =
30,856; p < 0.001); anxiety (X2 = 27.122; p < 0.001), OCD
(X2 = 17.341; p < 0.001), and lastly OCB (X2 = 13.551;
p < 0.001).
Premonitory Urges (PU) and Tic
Suppressibility
Of the total sample of 1032 participants, 291 (29.4%) individuals
did not report a PU [missing data, n = 41 (3.97%)]. Amongst
the 700 (67.82%) patients who did report the experience of a PU,
446 (46%) participants experienced a localized PU, 113 (11.6%) a
diffused PU, and for the remaining 141 (13.7%), although the PU
was present, its precise nature was uncertain. With regards to tic
suppression, 853 (85.4%) participants mentioned that they were
able to suppress their tics whereas 146 (14.6%) claimed that they
were unable to do so (missing data, n= 33).
In order to investigate age dependencies for both PU and
suppressibility, we used different age ranges: on the one hand we
used ranges based on the natural course of tics with the worst
period between ages 10 and 12 (Bloch et al., 2006)—<10 years,
10–12 years, >12 years (Table 6)—and on the other hand age
groups as suggested by Banaschewski et al. (2003): 8–10, 11–14,
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15–19 years. In addition to the latter age ranges, we looked at
PU and suppressibility in very young children (age<8 years) and
adults (age >19 years) to further investigate age dependency and
possible habituation (Table 7). Both classifications demonstrated
clear age dependencies for PU as well as tic suppression. Patients
who reported a PU suffered from significantly more severe tics
compared to those without PU [mean STSS-GSR= 2.87 vs. 2.62,
(t=−3.164; p< 0.005)]. In contrast, tic severity was not different
in patients who were able to suppress their tics compared to
those who were unable to do so [mean STSS-GSR = 2.83 vs.
2.63, (t = −1.830; n.s.)]. A significant positive association was
found between PU and the ability to suppress tics (X2 = 96.691;
p < 0.001).
While no significant association was found between PU and
OCD (X2 = 3.085; n.s.), we found a highly significant (X2 =
15.379; p < 0.001) positive association between PU and OCB. In
particular, there was a strong direct association between PU and
“not just right experiences” (X2 = 20.871; p < 0.001). Certain
other such significant positive associations were also found
between PU and obsessions (X2 = 11.218; p< 0.01), compulsions
in general (X2 = 26.769; p < 0.01), and various specific OC
symptoms including counting (X2 = 15.571; p < 0.01), checking
(X2 = 18.897; p < 0.01), ordering (X2 = 13.979; p < 0.01), but
not washing (X2 = 0.854; n.s.). Tic suppression was found to have
a significant and direct association with inattention (X2 = 6.056;
p < 0.05), rage attacks (X2 = 5.062; p < 0.05), and hyperactivity
(X2 = 4.838; p < 0.05).
TABLE 6 | PU, tic suppression, comorbidity score, and tic severity* based
on age ranges suggested by Bloch et al. (2006).
Age group
(years; N)
PU
reported
(%)
Ability to
suppress
tics (%)
Mean comorbidity
score (entire age
group)
Mean tic
severity (entire
age group)
<10 (181) 46.7 65.5 2.35 2.33
10–12 (195) 61.3 78.8 2.21 2.52
>12 (623) 79.7 92.6 2.91 3
*according to STSS-GSR
PU, premonitory urge; STSS-GSR, Global Severity Rating of the Shapiro Tourette-
Syndrome Severity Scale; N, numbers.
Comorbidities
Comorbidity Score
Across the entire sample, following were the percentages
of different comorbidity scores: 84 patients (8.2%) had no
comorbidity (“TS only”), 186 (18.1%) had one, 211 (20.5%) had
two, 226 (22%) had three, 175 (17%) had four, 109 (10.6%)
had five, and 36 (3.5%) had all six comorbidities as defined
above (OCD, anxiety, depression, SIB, rage attacks, and ADHD;
missing data: n = 5; see also Table 3). The mean comorbidity
score was 2.67 (range, 0–6; SD = 1.57). A significant positive
relationship was found between age groups and comorbidity
score [F(2) = 20.579; p < 0.001; Tables 6, 7]. Only 75 (7.67%) of
the individuals from the “TS group” presented with “TS only.”
Table 4 shows that in all those with a comorbidity score >1
(indicating the presence of any of the six comorbidities), the
mean tic severity tended to be significantly higher than in those
with no comorbidity. We also ran a test to compare the presence
of comorbidities in patients based on the following age groups:
<25,≥25 and<50, and≥50 years at the time of assessment. This
was done to check for recall issues in describing comorbidities
before and after a certain age. However, no significant differences
were found between the various age groups.
OCD/OCB
Whilst only 103 (10%) patients of the sample had been clinically
diagnosed with OCD according to DSM, 637 (61.8%) suffered
from mild to moderate OCB without fulfilling diagnostic criteria
for OCD. Table 8 shows prevalence rates for different forms of
OC symptoms amongst those with OCD and OCB. The most
often reported OC symptom was a “not just right experience” [in
575 (55.9%) patients across the entire sample].
ADHD, Rage Attacks
Hyperactivity was reported by 291 (28.4%) participants,
inattention by 405 (39.4%), and the diagnosis of ADHD
according to DSM was made in 463 (44.9%) individuals. As
expected, ADHD was significantly associated with hyperactivity
(X2 = 499.818; p < 0.001), inattention (X2 = 816.434;
p < 0.001), and rage attacks (X2 = 67.331; p < 0.01). However,
the association with rage attacks was comparatively much weaker
than that with the other two variables. Of the 594 patients
(57.8%) who were diagnosed with rage attacks, 261 (43.94%) did
TABLE 7 | PU, tic suppression, comorbidity score, and tic severity* compared to results provided by Banaschewski et al. (2003).
Age group years (N) Presence of premonitory feeling Ability to suppress tics Mean comorbidity score
(entire age group)
Mean tic severity
(entire age group)
Banaschewski
et al. (%)
Current
study (%)
Banaschewski
et al. (%)
Current
study (%)
<8 (80) – 34.8 – 56.5 2.23 2.34
8–10 (180) 34 61.8 48 75.1 2.36 2.39
11–14 (174) 56 61.8 66 82.8 2.35 2.66
15–19 (136) 68 76.6 79 90.6 2.62 2.92
>19 (429) – 81.3 – 93.4 3.03 3.05
*according to STSS-GSR, comorbidity score including OCD, anxiety, depression, SIB, rage attacks, and ADHD.
PU, premonitory urge; STSS-GSR, Global Severity Rating of the Shapiro Tourette-Syndrome Severity Scale.
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TABLE 8 | Prevalence rates of different forms of OC symptoms in TS
patients with comorbid OCD compared to those with comorbid OCB.
OC Symptom OCD (N; %) OCB (N; %) Z-score Significance
Compulsions 101 (98.1) 603 (94.9) 1.41 n.s.
-Not just right
experiences
87 (85.3) 467 (73.3) 2.38 n.s.
-Checking 77 (76.2) 279 (43.9) 5.02 p < 0.001
-Ordering 57 (55.9) 181 (28.4) 3.80 p < 0.001
-Washing 35 (34.7) 50 (7.8) 3.12 p < 0.01
-Counting 28 (27.7) 96 (15.1) 1.53 n.s.
Obsessions 92 (91.1) 262 (41.3) 8.25 p < 0.001
OC, obsessive-compulsive; OCD, obsessive-compulsive disorder; OCB, obsessive-
compulsive behavior; TS, Tourette Syndrome; N, numbers; n.s., not significant.
not suffer from either hyperactivity or inattention, thus giving
rise to the new and significant observation of the prevalence of
rage attacks in Tourette patients, often even in the absence of
ADHD.
Sleeping Problems
Sleeping problems (lifetime prevalence) were reported by 273
(26.7%) patients in the sample. Sleeping problems were found to
have strong direct associations with depression (X2 = 24.548;
p < 0.001), followed by ADHD (X2 = 14.785; p < 0.001),
anxiety (X2 = 12.088; p < 0.005), and OCD (X2 = 7.214;
p < 0.001). Its associations with tic severity (X2 = 5.097;
p < 0.05) and OCB were very weak (X2 = 4.879; p < 0.05).
Accordingly, sleeping problems were significantly more common
in the “TS+ comorbidity” group [n= 256 (28.7%)] compared to
patients with TS only [n= 4 (5.3%); Z = 4.3905; p < 0.01]. There
was also a significant positive association between the presence
of sleeping problems and the comorbidity score (X2 = 53.569;
p < 0.001).
Anxiety
The clinical lifetime diagnosis of any kind of an anxiety disorder
was made in 323 patients (31.4%). Prevalence rates for anxiety
were significantly higher amongst those with TS+OCD (55.6%,
n = 45) compared to those with TS+ADHD (16.8%, n = 102;
Z = 4.794; p < 0.01; refer to Table 4).
Depression
The lifetime diagnosis of depression was made in 236 patients
(22.9%). However, depression was found in 55.6% of the patients
with TS+OCD, but only in 9.9% of the TS+ADHD group,
resulting in a significant difference (Z = 5.988; p < 0.01; refer
to Table 4). A significant positive association was also found
between the prevalence of depression and anxiety (X2 = 69.083;
p < 0.001).
SIB
Lifetime prevalence of SIB was reported by 405 (39.4%) patients.
SIB was found to have a significant positive associations with the
presence of complex motor tics (X2 = 57.551; p < 0.01), OCB
(X2 = 32.026; p < 0.01), and anxiety (X2 = 31.634; p < 0.01),
in a descending order of the strength of the association (refer to
Table 4). For association with coprophenomena, see above.
Sub-Classification of TS
For the purpose of further exploring Robertson and Cavanna’s
(2007) sub-classification of TS and common comorbidities, the
three clusters provided by them were examined for expected
differences in certain variables: (i) cluster 1, which consists of
only tics (“TS only”; n = 75), (ii) cluster 2, which consists of
TS and comorbid ADHD and rage attacks (n = 56), and (iii)
cluster 3, which consists of TS and comorbid OCD, OCB, anxiety,
depression, and SIB (n = 209). Since we included only those
patients in clusters 2 and 3 who had all of the aforementioned
comorbidities (e.g., cluster 2 consisted of TS patients with both
comorbid ADHD and rage attacks, and not just one of the two),
only one-third of the total number of patients could be classified
using Robertson and Cavanna’s (2007) sub-classification criteria.
The rate of copropraxia in cluster 2 was 16.1 vs. 4.8% in cluster
3 and 2.7% in cluster 1, the difference between cluster 2 and
cluster 3 being significant in the direction of the hypothesis (X2 =
25.887; p< 0.001). The ability for tic suppression in the “TS only”
group was 91.7%, and was significantly higher than that in cluster
2 (78.2%) (Z = 2.1983; p < 0.05), but not significantly different
from that in cluster 3 (89.7%) (Z = 0.5004; n.s.). The percentage
of patients reporting PU based on the different clusters was the
following: cluster 1 (“TS only”): 57.7%, cluster 2: 62.3%, and
cluster 3: 75.1%. PU reported in cluster 3 was significantly higher
than that reported in cluster 1 (Z = 2.835; p < 0.001) but was not
significantly higher than PU reported in cluster 2 (Z = 1.9029;
n.s.).
Gender Differences
The male-to-female ratio in the current TS group is 3.4:1.
Table 9 shows results of gender-based comparisons of TS-related
phenomena from data obtained from all patients in the sample
demonstrating that males suffer more often from coprolalia,
copropraxia, palilalia, OCB, hyperactivity, and inattention. They
are alsomore likely to experience PU. Females, on the other hand,
are more likely than males to suffer from sleeping problems. No
significant gender differences were found with regards to age
at onset of both tic types in general, [t(963) = 0.022; n.s.], MT
[t(542) =−1.216; n.s.], and PT [t(951) = 1.489; n.s.]. No significant
relationship was found between comorbidity score and gender
[t(1025) = 1.398; n.s.].
DISCUSSION
In this study, we report clinical information collected from a
large sample of 1032 patients with different forms of primary
tic disorder. As two of the primary objectives of this study were
the exploration of the TS spectrum and the verification of the
accuracy of the sub-group classifications propounded by other
researchers, we concentrated on TS in association to its various
comorbidities.
Age at Onset and Tic Severity
The mean age at onset of tics in general, and MT and PT in
particular, were all found to be consistent with findings of other
studies (Freeman et al., 2000), but somewhat above the data in
TS literature. This could be because there was a high number
of adult participants in our study and since such data are always
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TABLE 9 | Gender differences in various TS-related aspects.
Males n (%) Mean
STSS-GSR
Females n (%) Mean
STSS-GSR
Z-Score p-value Significance Dominant
Gender
Coprophenomena 242 (30.4) 3.4 48 (20.3) 3.35 3.0205 0.002 p < 0.01 m > f
-Coprolalia 205 (25.9) 3.48 42 (17.8) 3.36 2.5161 0.01 p < 0.05 m > f
-Copropraxia 141 (17.8) 3.45 19 (8.1) 3.83 3.6019 0.0003 p < 0.01 m > f
Palilalia 278 (35.1) 3.19 68 (25.8) 3.35 1.7465 0.08 p < 0.01 m > f
Echolalia 231 (29.1) 3.22 59 (25) 3.18 1.2067 0.22 n.s. −
Echopraxia 183 (23.1) 3.19 55 (23.3) 3.22 −0.1009 0.92 n.s. −
OCD 72 (9.1) 3.04 31 (13.1) 3.41 −1.8411 0.06 n.s. −
OCB 509 (64) 2.91 128 (54.2) 2.94 2.6946 0.007 p < 0.01 m > f
Compulsions 552 (69.7) 2.83 153 (65.1) 2.97 1.3097 0.19 n.s. −
-Non Just Right Experiences 446 (56.2) 2.94 129 (54.7) 2.06 0.3719 0.71 n.s. −
-Ordering 185 (23.3) 3.18 53 (22.5) 3.17 0.251 0.80 n.s. −
-Checking 281 (35.5) 3.08 81 (34.3) 3.14 0.2769 0.77 n.s. −
-Counting 97 (12.3) 3.03 28 (11.9) 3.41 0.133 0.89 n.s. −
-Washing 66 (8.3) 2.72 20 (8.5) 3.05 −0.0894 0.92 n.s. −
Obsessions 273 (34.6) 3.02 84 (35.7) 2.93 −0.3115 0.75 n.s. −
Hyperactivity 294 (31.4) 2.97 42 (17.9) 2.97 5.51 <0.0000 p < 0.01 m > f
Inattention 337 (42.4) 2.9 68 (29.1) 3.03 3.5378 0.0004 p < 0.01 m > f
ADHD 387 (48.6) 2.92 76 (32.2) 2.92 4.4449 <0.0000 p < 0.01 m > f
Sleeping problems 198 (25.1) 2.97 75 (32.1) 3.11 −2.1122 0.03 p < 0.05 f > m
Anxiety 246 (31) 3.06 7 (32.8) 3.03 −0.5012 0.60 n.s. −
Depression 177 (22.3) 3.1 59 (25) 3.32 −0.8879 0.37 n.s. −
Rage attacks 460 (58) 2.93 134 (57) 3.07 0.2755 0.77 n.s. −
SIB 310 (38.9) 3.2 97 (41.1) 3.15 −0.5955 0.54 n.s. −
Severity of Tics* (severe) 67 (8.7) – 28 (12.2) – −1.6104 0.10 n.s. −
Premonitory urges 551 (72.3) 2.85 149 (65.1) 2.99 2.133 0.03 p < 0.05 m > f
Tic suppression 655 (85.2) 2.82 198 (86.1) 2.85 −0.3439 0.72 n.s. −
*according to STSS-GSR, severe, 5; very severe, 6 (range, 0–6).
OCD, obsessive-compulsive disorder; OCB, obsessive-compulsive behavior; ADHD, attention-deficit hyperactivity disorder; SIB, self-injurious behavior; TS, Tourette Syndrome;
STSS-GSR, Global Severity Rating of the Shapiro Tourette-Syndrome Severity Scale; n.s., not significant.
based on patient reports and memory, it is possible that there was
a recollection bias toward slightly greater age at onset, because
tic onset goes back many years, and thus could not be dated
precisely.
We found no association between tic severity and age at
onset, which is contradictory to previous research (Khalifa and
von Knorring, 2005). To the best of our knowledge, there is
almost no data available investigating specifically the association
between age at tic onset and tic severity, although this is an
important clinical question that is often asked by parents of
affected children. From our results, it is strongly—and for the
first time—suggested that there is no such association, although
one could easily expect this. This finding is in line with results of
the large clinical database by Freeman et al. (2000): although not
specifically mentioned, it can be concluded that in this dataset
there was also no association between age at tic onset and tic
severity, since they found no difference with respect to age at
tic onset depending on the presence of comorbidities (but more
severe tics in patients with comorbidities compared to those
without). When looking at the data by Khalifa and von Knorring
(2005) in more detail, the suggested correlation between tic
severity and age at onset appears questionable, since this was
found only in the very small group of patients with TS (n = 25),
but not in the larger group diagnosed with chronic motor/vocal
tics (n= 58).
We also found that for a majority of the participants in our
study, tic onset was much earlier than the age of 18 (refer to
Table 2). This is consistent with Freeman et al.’s (2000) finding,
where in 92.7% of the sample, tic onset was before 10 years of
age, and in 99% of the sample, it was before 16 years. Thus, data
from these two large datasets clearly confirm that the “18-year
maximum age of onset criterion” used in DSM-5 is well-founded
and should be maintained. In our sample, the median for tic
severity was found to be mild to moderate (median STSS-GSR=
3; 25th percentile = 2, 75th percentile = 4), which demonstrates
how rare extremely severe TS is, since even in a highly specialized
outpatient unit such as our center, 904 (87.6%) patients had mild
to moderate tics and only 95 (9.2%) had severe or very severe tics.
Our data do not demonstrate the well-known age dependency
of tic severity, but a continuous tic increase with increasing age.
However, this should be interpreted as a bias stemming from
the fact that this was a cross-sectional and not a longitudinal
study, tic assessment was done only once during the first medical
examination, and patients tend to come to the clinic when their
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tics get worse and usually not when their tics reduce. At our
center several patients present for the first only at adult age (with
or without having received the correct diagnosis of TS before). It
can be assumed that the majority of these patients belong to the
small group of those patients who suffer not only from persistent
tics, but also from more severe tics. This selection bias may be
the reason why we failed to demonstrate the well-known age
dependency of tics.
Completely in line with available data (Freeman et al., 2000),
tic severity was positively related to the comorbidity score
in that greater the number of comorbidities, higher the tic
severity, and also that those with one or more comorbidities
had significantly more severe tics than those without comorbid
disorders. Comorbid SIB was found to have the highest impact
on tic severity, followed by rage attacks, depression, anxiety,
OCD, and lastly, ADHD. In line with our hypothesis and
TS literature (Lebowitz et al., 2012), we also found that tic
severity was significantly greater in those with comorbid OCD
but no ADHD than in those with comorbid ADHD but no
OCB/OCD. These findings further corroborate the hypothesis
that TS plus OCD is a more severe form of TS, that OCB/OCD
is part of the TS spectrum, and that ADHD should be better
conceptualized as a separate problem (Trillini and Müller-Vahl,
2015).
Coprophenomena, Echophenomena, and
Paliphenomena
The prevalence rates of both coprolalia and copropraxia were
higher as compared to the percentages reported in Freeman
et al.’s study on coprophenomena, where the rate of coprolalia
ever was 18.5% and that of copropraxia was 5.7% (Freeman et al.,
2009), but were lower than those reported by Cavanna et al.
(2011), in which coprolalia and copropraxia were reported by
30.4 and 21.1% of the sample, respectively. The relatively high
prevalence rates reported in our study are possible due to the
fact that ours is a highly specialized clinic, where mostly patients
with several complex tics are referred. In addition, almost half
of our sample comprised adult patients. This might be another
reason for the higher prevalence rates of coprophenomena in our
sample, since the prevalence of coprophenomena increases with
age. Finally, all patients were specifically asked for the presence of
copro-, echo-, and paliphenomena.
The presence of all, coprophenomena, echophenomena, and
paliphenomena were associated with both tic severity and the
number of comorbidities, corroborating the hypothesis that “full
blown TS” is a more severe form of TS as suggested by Robertson
and Baron-Cohen (1998).
We also found that for both copro- and echophenomena, the
prevalence of the respective PT form (i.e. copro- and echolalia)
was higher than their corresponding MT form (copro- and
echopraxia). This is well-known (Freeman et al., 2000, 2009)
and suggests that copro- and echophenomena are, in a way,
different from simple tics, in which the frequency is vice-versa
(MT > PT). Assuming that tics present “fragments of innate
behavioral routines” as suggested recently (Leckman et al., 2013),
it can be speculated that copro-/echolalia are more common than
copro-/echopraxia, because swearing and repeating noises (such
as coughing) is nearer to “normal behavior” than performing
obscene gestures and the repetition of movements. However,
and in contrast, excessive brief movements such as eye blinking
and grimacing are “nearer to normal” than excessive fast and
meaningless noises.
In agreement with results from Freeman et al.’s database
(2009), we found that both coprolalia and copropraxia were
most highly associated with SIB, while associations with
other comorbidities were much weaker. The strong association
of coprophenomena with SIB, along with the equally high
association between SIB and complexmotor tics suggests that SIB
in TS belongs to the coprophenomena spectrum and is a complex
tic rather than an OC symptom, as has previously been suggested
(Mathews et al., 2004). However, Mathews et al. (2004) found a
correlation between OC symptoms and “mild SIB,” while “severe
SIB” correlated with tic severity and, therefore, they suggested the
presence of two distinct forms of SIB. In this study, no distinction
was made with respect to severity in a mild form (including hand
banging, compulsive skin picking, self-hitting, and lip biting) and
a severe form with serious injuries. In line with Mathews et al.’s
results (2004), we found no strong association between SIB and
rage attacks. Our finding that SIB had a higher impact on tic
severity than all other comorbidities (rage attacks, depression,
anxiety, OCD, and ADHD), in addition with the well-known
correlation between coprophenomena and tic severity (Freeman
et al., 2009), further suggests that SIB is a specific form of a
complex tic rather than an OC symptom. Our findings may have
important implications for the clinical management of SIB and
suggest the use of both behavioral therapy and antipsychotics
instead of serotonin reuptake inhibitors.
Prevalence rates of echolalia and echopraxia were found to
be lower than the rates reported by Eapen et al. in their 2004
paper (echolalia: 37.4%, n = 34; echopraxia: 29.9%, n = 27)
as well as those reported by Cavanna et al. (2011) [echolalia:
40.3%; echopraxia: 36.9%; (numbers not provided)], but higher
compared to other samples: echolalia: 16% (n = 32; Cardoso
et al., 1996) and echolalia: 21% and echopraxia: 18% (n = 71;
Neal and Cavanna, 2013). In our sample, the prevalence rate
for palilalia was found to be similar to that in Eapen et al.’s
(2004) sample (29.7%) as well as to Cavanna et al.’s (2011)
sample (31.7%). These differences may be due to the fact that
the prevalence rate for echophenomena and palilalia in any study
depends on whether the examiner asks the patient for relevant
symptoms, or only records what (s)he observes in the patient.
Furthermore, the way in which these questions are framed by
the examiner may also affect the prevalence rate. In the case of
echophenomena, the examiner in the present study specifically
asked all patients “when you seemovements and hear noises from
other people—independent of whether these are tics or normal
movements, or noises like coughing, or even noises from animals
or machines—have you ever felt that you had to imitate this?”
Only when the patient responded in the affirmative and said that
(s)he had acted accordingly was (s)he recorded as positive for the
echophenomenon. In any case, our data confirm the assumption
that echophenomena are a core symptom of TS (Ganos et al.,
2012).
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Premonitory Urges and Tic Suppression
Banaschewski et al. (2003) conducted a study to determine if
there is any age dependency of the presence of PU as well as
of tic suppression (refer to Table 7). In our study, we aimed
to replicate these findings. Our results were mixed in terms of
support for Banaschewski et al.’s findings. In general, PU and tic
suppression showed a clear age dependency. Secondly, although
PU and the ability to suppress tics were strongly associated, in
each age group, the percentage of patients who were capable of
tic suppression was greater than the percentage of those who
experienced a PU, indicating that tic suppression is possible
without necessarily being aware of a PU. However, there were
also some relevant differences between our results and those of
Banaschewski et al. Firstly, our results did not show “jumps”
for the development of either PUs or the ability to suppress
tics, unlike Banaschewski et al.’s findings, which suggested that
children develop the ability for tic suppression at around the
age of 10 years, and for PU around age 14. Secondly and most
important, the percentages of those patients who experience a PU
as well as those who could suppress their tics were much higher
at each age group compared to Banaschewski et al.’s study. We
found that both PU and tic suppressing ability is already present
in a high number of TS patients before the age of 8 (refer to
Table 7)—much earlier than previously thought. This indicates
that PU and suppression exist right from the beginning, and do
not develop during the course of TS. From our data, therefore,
it is suggested that the only reason that PU and tic suppression
cannot be seen in (very) young children is because they are
unable to either introspect or express them well-enough. This
has important implications with respect to the treatment with
habit reversal training and is in line with efficacy of this treatment
even in younger children as was demonstrated by Piacentini et al.
(2010).
On considering the age dependency based on the natural
history as described by Bloch et al. (2006), we found high
percentages of those who experienced PU and had the ability to
suppress tics at every age category. Here too, we observed a clear
age dependency, with a consistent increase of around 12–20% at
every successive age category.
Finally, our results also show that the higher the tic severity,
the more likely it is that the patient experiences a PU.
However, no such association was observed between tic severity
and tic suppression ability. With respect to Robertson and
Cavanna’s (2007) classification, we found that patients in cluster
3 (comorbid OCD/anxiety/depression/SIB) were almost equally
able to suppress their tics compared to those in cluster 1 (“TS
only”). However, a significant difference exists in tic suppression
between patients with TS only and patients in cluster 2 (comorbid
ADHD/rage attacks). This suggests that tic suppression is
independent from comorbid OCD/anxiety/depression/SIB, but
patients who suffer from ADHD are less able to suppress
their tics. Results also showed that PU was higher in the
“TS + comorbidity” group than in the “TS only” group,
which is supported by past findings (Eddy and Cavanna, 2013).
Particularly, it was highest in cluster 3 (including patients
with OCD/OCB/SIB/anxiety/depression), followed by cluster 2
(including patients with ADHD/rage attacks) and finally by the
group of patients having no comorbidities (cluster 1, “TS only”).
This too is in line with Eddy and Cavanna’s (2013) finding that
comorbidities such as anxiety, OCD, and ADHD are strongly
correlated with PU. Finally, our results also showed a strong
positive association between PU and “not just right experiences”
(and to a relatively lesser degree with OCB, but not OCD), which
indicates that PUmay be a form of this specific and very common
form of OCB in TS. This further corroborates the hypothesis that
“not just right experiences” are intrinsic to the phenomenology
of TS (Neal and Cavanna, 2013).
Influence of Comorbidities
The fact that only a small percentage of the TS sub-group had not
reported or were diagnosed with any comorbidity is consistent
with relevant literature (Freeman et al., 2000; Khalifa and von
Knorring, 2006; Cavanna et al., 2011; Robertson et al., 2015).
However, relative to the total TS population, this could be a
bias arising out of the method of data collection; the sample is
a clinical one and mostly, only patients with more severe tics and
more comorbidities come for a referral. This could be because
the quality of one’s life is impaired by common comorbidities of
TS far more than the tics themselves, as has been consistently
demonstrated in past literature (Pringsheim et al., 2009; Müller-
Vahl et al., 2010; Jalenques et al., 2012). Research has shown
that quality of life (Eddy et al., 2012) and psychosocial health
(Pringsheim et al., 2009) was most adversely affected on all
domains in those TS patients suffering from both comorbid
OCD and comorbid ADHD, whereas having only one of the
two comorbidities causes domain-specific impairment. Rizzo
et al. (2014) found a significantly lower quality of life among
those patients having TS+OCD/TS+ADHD/TS+OCD+ADHD
as compared to patients with pure TS. Studies have also
found comorbid depression to be one of the most significant
independent factors impairing the quality of life of TS patients
(Müller-Vahl et al., 2010; Jalenques et al., 2012).
In our sample, rage attacks were found to be themost common
comorbidity followed by ADHD. In contrast to this, Freeman
et al. (2000) found ADHD (60%) to be the most highly occurring
comorbidity. With respect to anxiety, depression, and SIB, the
sample in the current study showedmuch higher prevalence rates
compared to Freeman et al.’s sample, where 18, 12.1, and 14% had
anxiety, depression, and SIB respectively. All these differences in
prevalence rates of different comorbidities can probably be best
explained by age differences between our sample and Freeman
et al.’s sample (mean age = 18.9 vs. 13.2 years), as the older
the patients, the more likely it is that they have comorbidities
such as depression and sleeping problems and the younger they
are, the more likely it is that they have ADHD. The prevalence
rate of depression was also much higher than the 6.0% found
by Khalifa and von Knorring (2006), but this could be because
their sample consisted only of school children in the 7–15 years
age range. Our results, however, were very similar to the 27.8%
reported by Robertson et al. (2006). Cavanna et al. (2009), in their
review of the literature on the phenotype of TS stated that among
the 5295 patients with TS who presented at specialist clinics, the
prevalence rate of depressive symptomatology was found to range
from 13 to 76%.
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With respect to OC symptoms, we found a lower prevalence
rate for OCD compared to the Freeman et al.’s (2000) sample
in their 2000 paper (27%). This might be explained by the
fact that the evaluator (KMV) was extremely particular whilst
diagnosing OCD and often made the diagnosis of OCB, unless
all symptoms matched the prerequisites. However, the by far
most often reported OC symptom in both groups OCD and
OCB was a “non-just right experience” (refer to Table 8),
which corroborates recent findings suggesting that “not just
right experiences” are intrinsic to the clinical phenomenology
of TS (Neal and Cavanna, 2013). As described above, in this
context again it is worth mentioning that from our findings
it is suggested that premonitory urges (PU) prior to the
occurrence of tics may also be a form of a “non-just right
experience.” In addition, we found that among those who
had either OCD or OCB in our sample, compulsions such as
checking and ordering were much higher, whereas those of
counting and washing tended to be lower. This is in line with
past research in TS related OCD/OCB (Worbe et al., 2010).
According to Stewart et al. (2008), there are four factors for
OCD: factor 1 (aggressive/sexual/religious/somatic/checking);
factor 2 (symmetry/ordering/counting/repeating); factor 3
(contamination/cleaning), and factor 4 (hoarding). Of these,
only factor 2 was found to be common in TS, which further
supports the hypothesis that OCD/OCB in TS is different form
pure OCD.
We found that almost half the total number of patients
diagnosed with rage attacks did not have either hyperactivity
or inattention, which is consistent with the finding that rage
attacks, as compared to hyperactivity and inattention, is highly
common and represents one symptom of the typical spectrum of
disinhibited behaviors in TS that occurs in a substantial number
of patients independently from the presence of ADHD (Frank
et al., 2011). The assumption that rage attacks in TS are slightly
separate from and independent of the ADHD spectrum is further
supported by our finding that in our sample both inattention and
hyperactivity, but not rage attacks were more common in males
than in females.
Sleeping problems among the patients in our sample were
very common, and were found to be about five times as
common in the “TS + comorbidity” group as compared to the
“TS only” group. Such problems were most highly associated
with depression, indicating the well-stated finding that in TS
depression has a strong adverse effect on the patients’ quality
of life (Müller-Vahl et al., 2010; Eddy et al., 2011; Jalenques
et al., 2012). Other comorbidities (such as ADHD, anxiety, and
OCD, in a descending order of the strength of the association)
as well as tics (with lesser strength of association) may also
have an impact, but these associations were found to be much
weaker in comparison to depression. The strong association
between sleeping problems and depression has important clinical
implication: TS patients suffering from sleeping problems should
be screened for depression and, if necessary, treated for this
disorder. We found sleeping problems in the comorbid group
as twice as common in the comorbid group studied by Freeman
et al. (2000). This can be explained by the age difference between
both samples with more children in the Freeman et al.’s group
and the strong association with depression. Significantly higher
prevalence rates of both anxiety and depression in the TS+OCD
group as compared to the TS+ADHD group are in line with
previous research findings (Lebowitz et al., 2012; Trillini and
Müller-Vahl, 2015) and also provide support to our hypothesis
that TS is more closely related with OCD, anxiety, and depression
as compared to ADHD.
Influence of Gender
The male-to-female ratio in our sample was 3.4:1 and
therefore comparable to several other studies (Erenberg et al.,
1986; Freeman et al., 2000). In addition, results showed
significant predominance of males over females with respect to
coprophenomena (coprolalia, copropraxia, and overall), OCB,
hyperactivity, inattention, ADHD, and PU. A significantly greater
percentage of females in the sample had sleeping problems. In
contrast to our findings, past research in non-TS samples has
consistently shown twofold higher prevalence of anxiety and
depression in females over males (Bijl et al., 2002). In agreement
with recent studies in larger samples in both children (Robertson
et al., 2006) and mixed groups (Freeman et al., 2000), we did not
find gender differences with respect to anxiety and depression.
In contrast, in a recent internet-based survey (n = 460 adults)
women reported more often about both depressive symptoms
and non-OCD anxiety disorders (35.6 and 33.7%, respectively)
compared to men (23.2 and 15.5%, respectively; Lewin et al.,
2012). However, these results should be interpreted with caution
not only due to the well-known limitations related to such a
study design, but also other findings (e.g., insignificantly higher
prevalence rate for self-reported ADHD in female compared to
male). Thus, our results as well as past research (Freeman et al.,
2000; Robertson et al., 2006) suggest that the nature of both
depression and anxiety disorders in patients with TS differs from
that found in the general population. These disorders are a part
of the TS spectrum and are not only secondary due to tics and
an impaired quality of life. This, in addition, also supports the
assumption that the TS subgroup with comorbid OCD, anxiety,
and depression represents a more severe form of the disease.
We found no gender differences in the prevalence of rage
attacks. Since there is a general predominance of males over
females with respect to the prevalence of ADHD in ADHD-
only samples (Kessler et al., 2006), TS+ADHD samples (Freeman
et al., 2000), as well as in the current study sample, our finding of
similar prevalence rates of rage attacks for both genders is in line
with relevant literature (Frank et al., 2011) which shows that in
TS, rage attacks are independent and separate from ADHD.
Limitations
Our study has some noticeable limitations. Primarily, there
was an absence of a standardized assessment procedure and
diagnoses were made based on judgments of a single expert
clinician, thereby increasing the likelihood of errors caused
by various biases in evaluation. However, KMV is a highly
trained expert in both neurology and psychiatry and thus
had a rich experience in diagnosing movement disorders from
the very start of her career. Since most studies are carried
out by clinicians with less expertise in diagnosing TS, we do
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not see this is being any major disadvantage of our study.
Another limitation is a lack of temporal stability, since data
was collected over almost two decades and the diagnoses were
made based on the version of the DSM valid at that time. It
should be noted though, that the core criteria of tic disorders
did not change over time, therefore this should not be too
much of a concern. The cross-sectional nature of our data also
makes it difficult to learn about the temporal progression of tic
severity. Lastly, the possible effects of various medications on
tic suppression were not controlled for. It can be assumed that
using medication would improve one’s ability to suppress tics,
and therefore we cannot dismiss the idea that its use by some of
the patients influenced our results. However, to the best of our
knowledge, there is no study that looks particularly into such an
influence.
CONCLUSION
We believe that this study is the first single-site study on TS and
TS-related phenomena involving such a large sample. For the
first time, our results suggest that an early age of tic onset is not
necessarily associated with higher tic severity at subsequent ages.
Secondly, it has revealed that PU and tic suppression are
factors that are present from earlier than previously assumed
in past literature (Banaschewski et al., 2003). Both phenomena
seem to emerge in parallel to the tics rather than later in the
course of the disorder. Therefore, our data corroborate more
recent findings suggesting that PU is not a prerequisite for tic
suppression.
Thirdly, our data suggests that PU could represent of specific
type of OCB and in particular a “not just right experience.”
Fourthly, our data suggest that SIB belongs to the
coprophenomena spectrum and hence should be conceptualized
as a complex tic rather than a compulsion. This has important
implications for the treatment of severe SIB.
Fifthly, our results suggest that both depression and anxiety
disorders in patients with TS differ from their presentation
in non-TS samples. Sleeping problems are common in (adult)
patients with TS and are most often caused by comorbid
depression. Therefore, patients with TS reporting about sleeping
problems should be screened for comorbid depression.
Sixthly, rage attacks represent a typical symptom of
disinhibited behaviors in patients with TS. For clinicians it
is important to classify rage attacks as a manifestation of the
disease that often occur even in the absence of comorbid ADHD.
Seventhly, patients with TS and comorbid ADHD are less
able to suppress their tics when compared with those without
attention deficits.
Finally, our data demonstrate that TS+OCD is a more severe
form of the disease. Furthermore, our clinical data adds to other
clinical observations that subjects with ADHD may not be able
to suppress tics as well as those without ADHD. Synthesizing
all our data, we find support for the hypothesis that comorbid
OCD/OCB, depression, and anxiety belong to the TS spectrum,
while ADHD needs to be considered an independent diagnosis.
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